Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo

SIMPLE SUMMARY: Hepatocellular carcinoma (HCC), an advanced liver cancer, has poor prognosis and limited treatment options. Tumor Treating Fields (TTFields) therapy is a novel antimitotic treatment, delivering electric fields that induce death and inhibit replication of cancer cells. We aimed to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Davidi, Shiri, Jacobovitch, Sara, Shteingauz, Anna, Martinez-Conde, Antonia, Braten, Ori, Tempel-Brami, Catherine, Zeevi, Einav, Frechtel-Gerzi, Roni, Ene, Hila, Dor-On, Eyal, Voloshin, Tali, Tzchori, Itai, Haber, Adi, Giladi, Moshe, Kinzel, Adrian, Weinberg, Uri, Palti, Yoram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220990/
https://www.ncbi.nlm.nih.gov/pubmed/35740624
http://dx.doi.org/10.3390/cancers14122959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220990/
https://www.ncbi.nlm.nih.gov/pubmed/35740624
http://dx.doi.org/10.3390/cancers14122959

Ejemplares similares